Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Seminars in Arthritis & Rheumatism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/s0049-0172(97)80048-0PMID 9219315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

  1996cited by this paper
• Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs

  1995cited by this paper
• NSAIDs: time to re-evaluate gut toxicity.

  1994cited by this paper
• Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

  1994cited by this paper
• Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.

  1994cited by this paper
• Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs.

  1993cited by this paper
• Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy.

  1993cited by this paper
• Nonsteroidal anti‐inflammatory drug use in relation to major upper gastrointestinal bleeding

  1993cited by this paper
• The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease.

  1992cited by this paper
• Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan Countries Study on Upper Gastrointestinal Bleeding.

  1991cited by this paper
• Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee.

  1991cited by this paper
• Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.

  1991cited by this paper
• Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis.

  1991cited by this paper
• Dyspepsia in NSAID Users: The Size of the Problem

  1989cited by this paper
• Epidemiology of NSAID-related gastrointestinal side effects.

  1989cited by this paper
• The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs.

  1987cited by this paper
• NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCER

  1986cited by this paper

• Neuroprotective agents ineffective in mitigating autonomic dysreflexia following experimental spinal cord injury.

  2024cites this paper
• Nonsteroidal Anti-Inflammatory Drug-Gastropathy and Enteropathy

  2019cites this paper
• Caracterización del dolor y alteraciones músculo-esqueléticas en pacientes con dolor pélvico crónico. Propuesta de intervención terapéutica

  2019cites this paper
• A case–control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients

  2018cites this paper
• Production of aceclofenac-loaded sustained release micro/nanoparticles using pressure homogenization and spray drying

  2018cites this paper
• Pharmacological Management of Chronic Pelvic Pain in Women

  2017cites this paper
• Management for non-variceal upper gastrointestinal bleeding in elderly patients: the experience of a tertiary university hospital.

  2017influential citation
• Frequency and predictors of bleeding events after 2nd generation drug-eluting stent implantation differ depending on time after implantation.

  2017cites this paper
• When treating chronic pelvic pain in women, consider peripheral and central contributors

  2017cites this paper
• Myeloid cell involvement during the resolution of acute brain inflammation

  2016cites this paper
• New developments in the pharmacotherapy of neuropathic chronic pelvic pain

  2016cites this paper
• Development and optimization of sustained release polymeric microparticles by screening design

  2015influential citation
• PHARMACOKINETICS OF KETOPROFEN IN HEALTHY BUFFALO CALVES IN PAKISTAN

  2013cites this paper
• Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance

  2013cites this paper
• Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event

  2012cites this paper
• Impact of a health safety warning and prior authorisation on the use of piroxicam: a time‐series study

  2012cites this paper
• Pharmacokinetics of ketoprofen in healthy horses in Pakistan.

  2012cites this paper
• Tennis elbow.

  2011cites this paper
• Eco-Friendly Meloxicam Replaces Eco-Demaging Diclofenac Sodium in Veterinary Practice in South Asia-A Review

  2010cites this paper
• Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.

  2008cites this paper
• Tennis elbow.

  2008cites this paper
• A practical guide for clinicians

  2007cites this paper
• Peptic ulcer disease.

  2005cites this paper
• Learning pain assessment and management: a goal of the End-of-Life Nursing Education Consortium.

  2004cites this paper
• Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study

  2004cites this paper
• Over-the-Counter Analgesics in Older Adults

  2004cites this paper
• Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis

  2004cites this paper
• Evidence Based Medicine: Recommendations for Pharmacological Treatment of Osteoarthritis Patients

  2004cites this paper
• Motion--Cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs are as safe as placebo for the stomach: arguments for the motion.

  2003cites this paper
• Impact of Clinical Symptoms and Referral Volume on Endoscopy for Detecting Peptic Ulcer and Gastric Neoplasms

  2003cites this paper
• Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.

  2003cites this paper
• Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.

  2003cites this paper
• Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data.

  2003cites this paper
• Gastrointestinal Tolerability of Ibuprofen Compared with Paracetamol and Aspirin at Over-the-Counter Doses

  2002cites this paper
• Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark.

  2002cites this paper
• The safety of drugs for OTC use: what evidence is required for an NSAID switch?

  2002cites this paper
• Prevention of NSAID-induced gastroduodenal ulcers.

  2002cites this paper
• Do NSAIDs cause dyspepsia? a meta-analysis evaluating alternative dyspepsia definitions

  2002cites this paper
• A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs.

  2002cites this paper
• The use of anti-inflammatory drugs in cancer pain.

  2001cites this paper
• Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs.

  2001cites this paper
• Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs. Epidemiologic and economic issues.

  2001cites this paper
• Model of estimated rates of colorectal cancer from polyp growth by year of surveillance

  2001cites this paper
• COX-2 inhibitors compared and contrasted

  2001cites this paper
• COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile?

  2001cites this paper
• Endoscopic evaluation of the gastrotolerance of short‐term antalgic treatment with low dose k‐diclofenac: a comparison of ibuprofen and aspirin

  2001cites this paper
• COX-2 inhibition: an advance or only pharmaceutical "hype"?

  2001cites this paper
• Prevention of chronic NSAID induced upper gastrointestinal toxicity.

  2000cites this paper
• Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial.

  2000influential citation
• Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease

  2000cites this paper
• Cytokines in rheumatoid arthritis: trials and tribulations.

  2000cites this paper
• Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain.

  2000cites this paper
• Safety and efficacy of nabumetone in osteoarthritis: emphasis on gastrointestinal safety

  2000cites this paper
• Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain.

  2000cites this paper
• The clinical role of COX-2 inhibitors.

  2000cites this paper
• The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs: a review of the literature.

  2000cites this paper
• Are the biologic and clinical effects of the COX-2-specific inhibitors an advance compared with the effects of traditional NSAIDs?

  2000cites this paper
• [Consumption of non-steroidal anti-inflammatory drugs in basic health areas of the health region of Girona during 1997].

  2000cites this paper
• The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.

  2000cites this paper
• Toxicity of NSAIDs in the stomach and duodenum.

  1999cites this paper
• Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.

  1999cites this paper
• A comparison of shoe inserts in relieving mechanical heel pain

  1999cites this paper
• The use of analgesics in the management of pain in rheumatic diseases.

  1999cites this paper
• ects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis

  1999cites this paper
• Meta-analysis as a source of evidence in gastroenterology: a critical approach.

  1999cites this paper
• The effects of high-dose ibuprofen and pancreatic enzymes on the intestine of the rat.

  1999cites this paper
• Gastrointestinal safety profile of nabumetone: a meta-analysis.

  1999cites this paper
• Gastrointestinal safety and tolerance of ibuprofen at maximum over‐the‐counter dose

  1999cites this paper
• Selective cyclooxygenase-2 inhibitors.

  1999cites this paper
• Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis

  1999cites this paper
• The Cyclooxygenase-2 Inhibitors: Safety and Effectiveness

  1999cites this paper
• E ects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis

  1999cites this paper
• Comparative toxicity of nonsteroidal anti-inflammatory drugs.

  1999cites this paper
• Pain Treatment in Multimorbid Patients, the Older Population and Other High-Risk Groups

  1998cites this paper
• Send Orders of Reprints at Reprints@benthamscience.net Piroxicam---cyclodextrin: a Gi Safer Piroxicam

  year unknowncites this paper